Invention Grant
- Patent Title: Hepatitis C virus inhibitors
-
Application No.: US16094621Application Date: 2017-04-17
-
Publication No.: US10787441B2Publication Date: 2020-09-29
- Inventor: Joseph A. Kozlowski , Wensheng Yu , Bin Hu , Bin Zhong , Jinglai Hao , Dahai Wang , Zhixin Lei
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Jeffrey P. Bergman; Catherine D. Fitch
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@30dd08fb
- International Application: PCT/US2017/027850 WO 20170417
- International Announcement: WO2017/184476 WO 20171026
- Main IPC: A61K31/4178
- IPC: A61K31/4178 ; C07D405/14 ; A61K38/21 ; A61K38/19 ; A61K45/06
Abstract:
A compound of Formula (I) or (II), for treating or preventing an HCV infection in a subject.
Public/Granted literature
- US20190127355A1 HEPATITIS C VIRUS INHIBITORS Public/Granted day:2019-05-02
Information query
IPC分类:
